Back
Regal Rexnord Vs. MoonLake Immunotherapeutics Industry Stock Comparison
Buy
51
RRX
Regal Rexnord
Last Price:
163.53
Seasonality Move:
2.18%
Buy
77
MLTX
MoonLake Immunotherapeutics
Last Price:
51.00
Seasonality Move:
10.4%
Buy
51
Regal Rexnord (RRX)
is a Buy
Is Regal Rexnord a Buy, Sell or Hold?
- The current Regal Rexnord [RRX] share price is $163.75. The Score for RRX is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- RRX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
77
MoonLake Immunotherapeutics (MLTX)
is a Buy
Is MoonLake Immunotherapeutics a Buy, Sell or Hold?
- The current MoonLake Immunotherapeutics [MLTX] share price is $50.99. The Score for MLTX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
- MLTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RRX Stock Price Chart
What is Regal Rexnord's stock price today?
-
The Regal Rexnord share price today is $163.75
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
MLTX Stock Price Chart
What is MoonLake Immunotherapeutics's stock price today?
-
The MoonLake Immunotherapeutics share price today is $50.99
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MLTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
RRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 60.56 | Buy |
| Chaikin Money Flow: | 323039 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (151 - 163.9) | Buy |
| Bollinger Bands (100): | (142.01 - 161.33) | Buy |
MLTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.09 | Buy |
| Relative Strength Index (14 RSI): | 62.93 | Buy |
| Chaikin Money Flow: | 418016 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
RRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 152.06 | Buy |
| 20-day SMA: | 157.56 | Buy |
| 50-day SMA: | 154.05 | Buy |
| 200-day SMA: | 152.84 | Buy |
| 8-day EMA: | 155.31 | Buy |
| 20-day EMA: | 155.44 | Buy |
| 50-day EMA: | 154.16 | Buy |
| 200-day EMA: | 151.27 | Buy |
MLTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.62 | Buy |
| 20-day SMA: | 48.07 | Buy |
| 50-day SMA: | 46.34 | Buy |
| 200-day SMA: | 48.42 | Buy |
| 8-day EMA: | 49.24 | Buy |
| 20-day EMA: | 48.01 | Buy |
| 50-day EMA: | 46.45 | Buy |
| 200-day EMA: | 45.68 | Buy |
Regal Rexnord Earnings Growth & RRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.49 per share, an increase this year of $0.36 per share, and an increase next year of $1.98 per share.
MoonLake Immunotherapeutics Earnings Growth & MLTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.20 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.79 per share.
Regal Rexnord Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
MoonLake Immunotherapeutics Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||